{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T18:40:04Z","timestamp":1740249604021,"version":"3.37.3"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.nuclcard.2025.102150","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T15:31:19Z","timestamp":1739460679000},"page":"102150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Amyloidosis imaging in focus: The evolution of bone-avid cardiac scintigraphy in the era of disease-modifying therapies"],"prefix":"10.1016","volume":"44","author":[{"given":"Marcelo F.","family":"Di Carli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nuclcard.2025.102150_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.101940","article-title":"Correlation between technetium-99m pyrophosphate myocardial uptake and extracellular volume on cardiac magnetic resonance imaging in patients with transthyretin cardiac amyloidosis","author":"Khoo","year":"2024","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102150_bib2","article-title":"Assessing the effectiveness of tafamidis therapy in patients with transthyretin cardiac amyloidosis using (99m)technetium pyrophosphate cardiac imaging","author":"Tasaka","year":"2024","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102150_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.102019","article-title":"Quantitative (99m)Tc-pyrophosphate myocardial uptake: changes on transthyretin stabilization therapy","author":"Vijayakumar","year":"2024","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102150_bib4","article-title":"Current practices in amyloidosis imaging with bone-avid tracer cardiac scintigraphy","author":"Cuddy","year":"2024","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102150_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.101970","article-title":"Automatic motion correction for myocardial blood flow estimation improves diagnostic performance for coronary artery disease in (18)F-flurpiridaz positron emission tomography-myocardial perfusion imaging","author":"Builoff","year":"2024","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102150_bib6","article-title":"Prognostic value of transient ischemic dilation on Rubidium-82 positron emission tomography myocardial perfusion imaging","author":"Patel","year":"2024","journal-title":"J\u00a0Nucl Cardiol"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358125000248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358125000248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T17:58:09Z","timestamp":1740247089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358125000248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":6,"alternative-id":["S1071358125000248"],"URL":"https:\/\/doi.org\/10.1016\/j.nuclcard.2025.102150","relation":{},"ISSN":["1071-3581"],"issn-type":[{"type":"print","value":"1071-3581"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyloidosis imaging in focus: The evolution of bone-avid cardiac scintigraphy in the era of disease-modifying therapies","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nuclcard.2025.102150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of American Society of Nuclear Cardiology.","name":"copyright","label":"Copyright"}],"article-number":"102150"}}